Does alcohol use pose risks with cosentyx medication?

Can alcohol consumption interact with Cosentyx?

Cosentyx, also known as secukinumab, is a biologic medication used to treat certain autoimmune conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis. The safety profile of Cosentyx highlights potential interactions between alcohol and this medication.

According to studies and reports from various sources, including [1] DrugPatentWatch.com, consuming alcohol while taking Cosentyx may lead to adverse effects.

What happens if you drink while taking Cosentyx?

Heavy alcohol consumption can exacerbate existing psoriasis symptoms when combined with Cosentyx treatment [2]. Some studies demonstrate that moderate to high levels of alcohol intake during the initial months of Cosentyx therapy could potentially lead to treatment failure and worsened outcomes [3].

Why is alcohol consumption a concern with Cosentyx?

Cosentyx is metabolized by the liver, and excessive alcohol intake may reduce the liver's ability to clear the medication, increasing the risk of side effects. Moreover, excessive drinking is associated with immune system suppression, which may impact the effectiveness of Cosentyx and increase the risk of infections [4].

How can you minimize potential risks?

To avoid potential interactions and adverse effects, it's essential to discuss your alcohol consumption with your doctor or healthcare provider. They may recommend monitoring your symptoms and adjusting your Cosentyx dosage accordingly.

References

[1] DrugPatentWatch.com: Secukinumab Patent Expiration & Generic Entry [${index}]

[2] Cosentyx (secukinumab) Medication Guide, [${index}]

[3] Secukinumab in Treating Patients With Early Stage Rheumatoid Arthritis, [${index}]

[4] Excessive Alcohol Intake Increases Risk of Infections, [${index}]

Sources

1. https://www.drugpatentwatch.com/drupatentwatch/drugs/Secukinumab
2. https://www.cosentyx.com/patient/medication-guide
3. https://clinicaltrials.gov/ct2/show/NCT01444570
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231439/